Nazara Technologies announced the infusion of USD 77.00 million (approximately ₹734.35 Crores) into its wholly-owned subsidiary, Nazara UK. This capital injection is part of the second tranche payment towards the acquisition of ‘Target Companies’ under an Amended and Restated Share Purchase Agreement. The company also disclosed that USD 77.00 million was paid as the second tranche, with the balance consideration to be discharged as per the agreement, reinforcing Nazara UK’s ownership of the Target Companies.
Nazara Technologies Updates Acquisition Status
Nazara Technologies Limited has provided an update on its ongoing acquisition of ‘Target Companies’ through its wholly-owned subsidiary, Nazara UK. In line with previous disclosures and the Amended and Restated Share Purchase Agreement, the company has infused USD 77.00 million (equivalent to approximately ₹734.35 Crores) into Nazara UK on October 29, 2026. This infusion was made via subscription to Nazara UK’s equity shares, subject to applicable laws.
Acquisition Tranche and Consideration
Further to this, on October 30, 2026, Nazara UK made a cash payment of USD 77.00 million (equivalent to approximately ₹734.35 Crores) as the second tranche. This payment forms part of the total consideration of USD 303.02 million (equivalent to approximately ₹2990 Crores) payable by Nazara UK to the Sellers for the acquisition of the Target Companies. The remaining balance of the consideration will be discharged as outlined in the Amended SPA, with further updates to follow.
Subsidiary Structure Update
Consequently, the ‘Target Companies’ continue to operate as wholly-owned subsidiaries of Nazara UK, and thereby as step-down subsidiaries of Nazara Technologies Limited.
Source: BSE
